The Economist’s 8th Annual World Cancer Series Europe
Europe convenes a wide range of stakeholders critical to effective cancer care, to drive innovation, equity and excellence in cancer control across Europe.
The focus of this year’s conference is ”innovation, equity and excellence”. The aim of the event is to identify strategies to accelerate innovation, reduce inequities across cancer control in Europe, and to build towards universally excellent cancer control and cancer outcomes across the continent.
This timely and important discussion occurs against the backdrop of implementing the EU Beating Cancer Plan, recovery from the coronavirus pandemic, and a Europe facing security challenges and a major refugee crisis.
ECPC has been invited and will be represented by the President, Francesco de Lorenzo, who will participate in the panel: Which novel biomarkers are changing patient outcomes? on November 9, from 15:15 to 15:55 CET. ECPC Director, Dr. Charis Girvalaki, will speak at the panel: Improving access to innovative medicines on November 9, from 11:50 to 12:30 CET.
ECPC Scientific Committee member Dr. Françoise Meunier will give a speech The Right to be forgotten on November 9, from 10:35 to 10:55 CET. Also, Prof. Mark Lawler will be speaking at the event Fireside chat: Cancer knows no borders; lessons from the All Ireland Cancer Consortium, on 8th November, from 16:15 to 17:00 CET. Click here for more information on the agenda.
|📆 When: 8 – 9 November 2022||📍 Where: Marriott Hotel Grand Place, Brussels|